Titre : | Not for human consumption. An updated and amended status report on new psychoactive substances (NPS) and 'club drugs' in the UK |
Auteurs : | H. SHAPIRO |
Type de document : | Rapport |
Editeur : | London : DrugScope, 2015 |
Format : | 45 p. |
Langues: | Anglais |
Discipline : | SAN (Santé publique / Public health) |
Mots-clés : |
Thésaurus géographique ROYAUME-UNIThésaurus mots-clés DROGUES DE SYNTHESE ; CANNABINOIDES ; STIMULANTS ; HALLUCINOGENES ; OPIACES ; MEPHEDRONE ; SURVEILLANCE EPIDEMIOLOGIQUE ; MARCHE DE LA DROGUE ; LEGISLATION ; INTERVENTION ; PREVENTION ; MORTALITE |
Résumé : |
All the available official data indicates that, albeit with some recent blips and changing patterns of use, in general terms, non-medical drug use in the UK has been in decline since the start of this century.
However, since around 2008, there has been a growing interest in, and availability of, a new generation of drugs which are currently called collectively New (or Novel) Psychoactive Substances (NPS). The arrival of NPS has been something of a 'game-changer' in that traditional models of drug diffusion and supply (e.g., for heroin or cocaine) have been joined by the internet as a new supply route - while (currently) many of the NPS are also available in high street retail outlets without legal restraint. However, following on from the recommendations of the Home Office NPS Review Panel and recent local court judgements, the high street sale and distribution of NPS will become increasingly difficult. The citing of NPS patterns and prevalence of use and treatment needs in official datasets remains patchy, but from what exists plus a growing body of anecdotal evidence and unofficial reporting - a picture is emerging of NPS use in the UK in 2015. [...] As revealed by Druglink's 2014 Street Drug Survey, the other main group of new drugs causing a range of problems are the synthetic cannabinoids - from acute incidents requiring hospitalisation to dependency - especially among vulnerable young people, young offender and prison populations and, again, among traditional drug service clients. While NPS have been mentioned in a number of fatalities, very few deaths appear to have been as a direct result of taking an NPS in isolation. The issue of providing up to date and credible information in such a new and rapidly developing scenario is problematic - and there is a danger of over-reacting to the situation. For drugs workers, the key message is to 'deal with the problem in front of you' rather than being overly concerned about the substance that is alleged to have been taken. At the time of writing, some useful clinical guidance is in preparation under the auspices of Project Neptune (London Club Drug Clinic). It is also clear that a range of other drugs (loosely called 'club drugs') are causing some serious health concerns and these should also be taken into account when devising health and prevention strategies around NPS to include 'older drugs causing newer problems'. In particular there has been a significant increase in the number of MDMA and MDMA/PMA related deaths in recent years. [Extract] |
Domaine : | Drogues illicites / Illicit drugs |
Affiliation : | UK |
Lien : | https://drugscopelegacysite.files.wordpress.com/2015/07/not-for-human-consumption.pdf |
Titre précédent : | |
Titre suivant : |
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Accueil